FOLD vs. WRN

Last updated Apr 1, 2026

Compare and contrast key facts about Amicus Therapeutics, Inc. (FOLD) and Western Copper and Gold Corporation (WRN).

Performance

FOLD vs. WRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amicus Therapeutics, Inc. (FOLD) and Western Copper and Gold Corporation (WRN). The values are adjusted to include any dividend payments, if applicable.

FOLD vs. WRN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FOLD Amicus Therapeutics, Inc.	1.54%	51.17%	-33.62%	16.22%	5.71%	-49.98%	137.06%	1.67%	-33.43%	189.54%
WRN Western Copper and Gold Corporation	-5.24%	154.29%	-21.05%	-25.28%	14.10%	26.83%	49.11%	83.31%	-55.45%	-26.81%

Fundamentals

Market Cap FOLD : $4.55B WRN : $511.91M
EPS FOLD : -$0.09 WRN : -$0.02
PB Ratio FOLD : 16.58 WRN : 2.65
Total Revenue (TTM) FOLD : $634.21M WRN : $0.00
Gross Profit (TTM) FOLD : $561.28M WRN : -$97.53K
EBITDA (TTM) FOLD : $42.38M WRN : -$7.37M

Returns By Period

In the year-to-date period, FOLD achieves a 1.54% return, which is significantly higher than WRN's -5.24% return. Over the past 10 years, FOLD has underperformed WRN with an annualized return of 5.22%, while WRN has yielded a comparatively higher 17.37% annualized return.

FOLD

• 1D: 0.21%
• 1M: 0.63%
• YTD: 1.54%
• 6M: 83.50%
• 1Y: 77.21%
• 3Y*: 9.25%
• 5Y*: 7.53%
• 10Y*: 5.22%

WRN

• 1D: 5.86%
• 1M: -26.88%
• YTD: -5.24%
• 6M: 28.43%
• 1Y: 122.91%
• 3Y*: 11.40%
• 5Y*: 14.24%
• 10Y*: 17.37%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FOLD vs. WRN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FOLD

FOLD Risk / Return Rank: 84
FOLD Sharpe Ratio Rank: 86
FOLD Sortino Ratio Rank: 88
FOLD Omega Ratio Rank: 90
FOLD Calmar Ratio Rank: 80
FOLD Martin Ratio Rank: 77

WRN

WRN Risk / Return Rank: 85
WRN Sharpe Ratio Rank: 89
WRN Sortino Ratio Rank: 83
WRN Omega Ratio Rank: 82
WRN Calmar Ratio Rank: 84
WRN Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FOLD vs. WRN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amicus Therapeutics, Inc. (FOLD) and Western Copper and Gold Corporation (WRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FOLD	WRN	Difference
Sharpe ratio Return per unit of total volatility	1.63	1.83	-0.20
Sortino ratio Return per unit of downside risk	2.67	2.25	+0.41
Omega ratio Gain probability vs. loss probability	1.40	1.29	+0.11
Calmar ratio Return relative to maximum drawdown	2.32	2.72	-0.41
Martin ratio Return relative to average drawdown	5.16	8.12	-2.96
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FOLD vs. WRN - Sharpe Ratio Comparison

The current FOLD Sharpe Ratio is 1.63, which is comparable to the WRN Sharpe Ratio of 1.83. The chart below compares the historical Sharpe Ratios of FOLD and WRN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FOLD	WRN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.63	1.83	-0.20
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.16	0.25	-0.08
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.09	0.28	-0.19
Sharpe Ratio (All Time) Calculated using the full available price history	0.00	0.03	-0.03

Correlation

The correlation between FOLD and WRN is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

FOLD vs. WRN - Dividend Comparison

Neither FOLD nor WRN has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

FOLD vs. WRN - Drawdown Comparison

The maximum FOLD drawdown since its inception was -89.91%, smaller than the maximum WRN drawdown of -95.24%. Use the drawdown chart below to compare losses from any high point for FOLD and WRN.

Drawdown Indicators

	FOLD	WRN	Difference
Max Drawdown Largest peak-to-trough decline	-89.91%	-95.24%	+5.33%
Max Drawdown (1Y) Largest decline over 1 year	-29.50%	-42.72%	+13.22%
Max Drawdown (5Y) Largest decline over 5 years	-61.16%	-65.53%	+4.37%
Max Drawdown (10Y) Largest decline over 10 years	-77.34%	-80.15%	+2.81%
Current Drawdown Current decline from peak	-41.90%	-40.34%	-1.56%
Average Drawdown Average peak-to-trough decline	-53.81%	-64.71%	+10.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.86%	14.31%	-0.45%

Volatility

FOLD vs. WRN - Volatility Comparison

The current volatility for Amicus Therapeutics, Inc. (FOLD) is 0.56%, while Western Copper and Gold Corporation (WRN) has a volatility of 21.38%. This indicates that FOLD experiences smaller price fluctuations and is considered to be less risky than WRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FOLD	WRN	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.56%	21.38%	-20.82%
Volatility (6M) Calculated over the trailing 6-month period	30.44%	55.40%	-24.96%
Volatility (1Y) Calculated over the trailing 1-year period	47.84%	67.98%	-20.14%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.15%	58.49%	-11.34%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	55.54%	62.14%	-6.60%

Financials